Inventor · disambiguated record
Jetze J. Tepe
Also filed as: TEPE JETZE · TEPE JETZE J
18 granted patents·10 pending applications·75 citations·filing 2003–2024
93Inventor score
Files withUNIV MICHIGAN STATE23TEPE JETZE2TEPE JETZE J1THE BOARD OF REGENTS OF THE UNIVERSY OF TEXAS SYSTEM1UNIV TEXAS1
Top patents by PatentIndex Score
28 records- 0192US7335769B2Preparation of hymenialdsine derivatives and use thereofUNIV MICHIGAN STATE·Filed 2006·Granted Feb 26, 2008·15 cites·2 claims
- 0292US7193079B1Preparation of hymenialdisine derivatives and use thereofUNIV MICHIGAN STATE·Filed 2006·Granted Mar 20, 2007·17 cites·5 claims
- 0385US7385055B2Preparation of hymenialdisine derivatives and use thereofUNIV MICHIGAN STATE·Filed 2004·Granted Jun 10, 2008·15 cites·3 claims
- 0484US7732436B2Preparation of hymenialdisine derivatives and use thereofUNIV MICHIGAN STATE·Filed 2006·Granted Jun 8, 2010·5 cites·6 claims
- 0579US8252942B2Substituted imidazoline compoundsTEPE JETZE·Filed 2008·Granted Aug 28, 2012·3 cites·1 claims
- 0675US7652056B2Multi-substituted imidazolines and method of use thereofUNIV MICHIGAN STATE·Filed 2005·Granted Jan 26, 2010·1 cites·7 claims
- 0775US7528161B2NF-kappaB inhibitors and uses thereofUNIV MICHIGAN STATE·Filed 2003·Granted May 5, 2009·5 cites·8 claims
- 0874US8552206B2NF-κB inhibitors and uses thereofTEPE JETZE J·Filed 2009·Granted Oct 8, 2013·2 cites·11 claims
- 0973US11358942B2Substituted phenothiazines as proteasome activatorsUNIV MICHIGAN STATE·Filed 2018·Granted Jun 14, 2022·1 cites·9 claims
- 1073US7858808B2Multi-substituted imidazolines and method of use thereofUNIV MICHIGAN STATE·Filed 2010·Granted Dec 28, 2010·1 cites·4 claims
- 1172US6878735B2Multi-substituted imidazolines and method of use thereofUNIV MICHIGAN STATE·Filed 2003·Granted Apr 12, 2005·5 cites·20 claims
- 1270US7345078B2NF-κB inhibitors and uses thereofUNIV MICHIGAN STATE·Filed 2003·Granted Mar 18, 2008·5 cites·7 claims
- 1369US12084421B2Quinoline-based proteasome inhibitors and uses thereofUNIV MICHIGAN STATE·Filed 2021·Granted Sep 10, 2024·0 cites·19 claims
- 1467US12060337B2Substituted dibenzo[b, f]azepines as proteasome activatorsUNIV MICHIGAN STATE·Filed 2022·Granted Aug 13, 2024·0 cites·19 claims
- 1564US2022087979A1Treatment of malignanciesUNIV MICHIGAN STATE·Filed 2021·Application pending·0 cites
- 1663US2024423968A1Use of proteasome-targeting small molecules to mitigate muscle wastingUNIV TEXAS·Filed 2024·Application pending·0 cites
- 1763US2025179031A1Proteasome enhancers and uses thereofUNIV MICHIGAN STATE·Filed 2023·Application pending·0 cites
- 1861US7601710B2Preparation of hymenialdisine derivatives and use thereofUNIV MICHIGAN STATE·Filed 2006·Granted Oct 13, 2009·0 cites·7 claims
- 1959US2020347019A1Quinoline-based proteasome inhibitors and uses thereofUNIV MICHIGAN STATE·Filed 2020·Application pending·0 cites
- 2057US10752590B2Quinoline-based proteasome inhibitors and uses thereofUNIV MICHIGAN STATE·Filed 2018·Granted Aug 25, 2020·0 cites·9 claims
- 2156US2023295116A1Proteasome enhancers and uses thereofUNIV MICHIGAN STATE·Filed 2021·Application pending·0 cites
- 2256US2023286982A1Proteasome enhancers and uses thereofUNIV MICHIGAN STATE·Filed 2021·Application pending·0 cites
- 2356US2024043394A1Proteasome enhancers and uses thereofUNIV MICHIGAN STATE·Filed 2021·Application pending·0 cites
- 2449US2013338372A1Substituted Imidazoline CompoundsTEPE JETZE·Filed 2012·Application pending·0 cites
- 2549US2019030002A1Treatment of malignanciesUNIV MICHIGAN STATE·Filed 2018·Application pending·0 cites
- 2646US7423132B2Method for the enrichment and characterization of phosphorylated peptides or proteinsUNIV MICHIGAN STATE·Filed 2005·Granted Sep 9, 2008·0 cites·44 claims
- 2744US2008114015A1NF-kB inhibitors and uses thereofUNIV MICHIGAN STATE·Filed 2006·Application pending·0 cites
- 2834US11345659B2Pipecolic esters for inhibition of the proteasomeTHE BOARD OF REGENTS OF THE UNIVERSY OF TEXAS SYSTEM·Filed 2019·Granted May 31, 2022·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →